about

We offer the latest timely and accurate Testosterone articles covering all commonly available forms of Testosterone.

If you are considering purchasing Testosterone then let us give you the facts you need!

Delatestryl > Lexington

January 2009
SunMonTueWedThuFriSat
 123
45678910
11121314151617
18192021222324
25262728293031

Please select a testosterone article from the list below:

Cities

Province/States

Country

Friday 1st of September 2006

Business Wire - Indevus Pharmaceuticals Scheduled to Present at Thomas Weisel Partners Healthcare Conference 2006

Friday 1st of September 2006, 12:00 am

September 1, 2006 -- LEXINGTON, Mass. -- Indevus Pharmaceuticals, Inc. (NASDAQ: IDEV) today announced that the Company will present at the Thomas Weisel Partners...

Thursday 31st of August 2006

Business Wire - Indevus Pharmaceuticals Scheduled to Present at BioCentury NewsMakers in the Biotech Industry Conference

Thursday 31st of August 2006, 12:00 am

August 31, 2006 -- LEXINGTON, Mass. -- Indevus Pharmaceuticals, Inc. (NASDAQ: IDEV) today announced that the Company will present at the NewsMakers in the Biotech...

Thursday 8th of June 2006

Business Wire - Indevus to Present at 2006 Pacific Growth Equities Life Sciences Growth Conference

Thursday 8th of June 2006, 12:00 am

June 8, 2006 -- LEXINGTON, Mass. -- Indevus Pharmaceuticals, Inc. (NASDAQ: IDEV) today announced that it will present at the 2006 Pacific Growth Equities Life...

Monday 9th of January 2006

Business Wire - Indevus Announces Closing of Delatestryl® Transaction

Monday 9th of January 2006, 12:00 am

January 9, 2006 -- LEXINGTON, Mass. -- Indevus Pharmaceuticals, Inc. (NASDAQ: IDEV) today announced the closing of the previously announced acquisition of the U.S....

Tuesday 13th of December 2005

Business Wire - Indevus Pharmaceuticals Announces Fiscal 2005 Year End and Fourth Quarter Results; Company Acquires Rights to Delatestryl®; Company Finalizes NDA...

Tuesday 13th of December 2005, 12:00 am

December 13, 2005 -- LEXINGTON, Mass. -- Indevus Pharmaceuticals, Inc. (NASDAQ: IDEV) today announced its consolidated results of operations for the fiscal year and the...

Business Wire - Savient Pharmaceuticals Agrees to Sale of Delatestryl® to Indevus Pharmaceuticals

Tuesday 13th of December 2005, 12:00 am

December 13, 2005 -- EAST BRUNSWICK, N.J. -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNTE) an emerging specialty pharmaceuticals company focused on developing,...





Powered by Odin Assemble